Table 4.
The prognostic value of PLAAT4 (Overall Survival) in subgroups of patients with pancreatic cancer.
| Characteristics | N (%) | HR (95% CI) | P value |
|---|---|---|---|
| T stage | |||
| T1 & T2 | 31 (17) | 1.95 (0.55–6.92) | 0.299 |
| T3 & T4 | 145 (83) | 1.69 (1.08–2.62) | 0.02 |
| N stage | |||
| N0 | 50 (28.9) | 1.58 (0.59–4.20) | 0.364 |
| N1 | 123 (71.1) | 1.33 (0.83–2.11) | 0.231 |
| M stage | |||
| M0 | 79 (94) | 1.94 (1.02–3.70) | 0.045 |
| M1 | 5 (6) | – | – |
| Pathologic stage | |||
| Stage I & Stage II | 167 (96) | 1.71 (1.12–2.62) | 0.013 |
| Stage III & Stage IV | 8 (4) | – | – |
| Histologic grade | |||
| G1 & G2 | 126 (71) | 1.79 (1.05–3.07) | 0.033 |
| G4 & G3 | 50 (29) | 1.35 (0.66–2.74) | 0.409 |